Search

everythinglearnresearchcommunity

for

Search:↓

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Using a vibrating device during injections can help reduce pain.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

The combination therapy effectively improved acne keloidalis nuchae.

The cephalic approach for nerve blocks is less painful than the anterior approach during hair restoration surgery.

Presynaptic inhibition of certain nerve fibers in cats is mainly controlled by GABA and glycine.

The new treatment showed promise in managing eyebrow hair loss.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Health Education England is moving forward with phase two of their cosmetic intervention project after a successful summit and plans for future training standards.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Scalp abscesses can occur after hair loss treatments and may be caused by Mycobacterium abscessus.

Cooling the skin before injections reduces pain for patients with hair loss.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Accidental injection of hyaluronic acid caused temporary hair loss and skin damage, but treatment restored hair and healed the skin.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

β-interferon injections for melanoma can cause excessive hair growth at the injection sites.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

Tacalcitol ointment effectively improves bilateral nevus comedonicus.

The new gel provides faster and longer-lasting pain relief than the cream.

A new microneedle treatment shows promise for better hair regrowth in androgenetic alopecia.